Biostem Technologies Stock Probability of Future OTC Stock Price Finishing Under 7.11
| BSEM Stock | USD 14.44 0.98 6.36% |
Biostem |
Biostem Technologies Target Price Odds to finish below 7.11
The tendency of Biostem OTC Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to drop to $ 7.11 or more in 90 days |
| 14.44 | 90 days | 7.11 | roughly 2.87 |
Based on a normal probability distribution, the odds of Biostem Technologies to drop to $ 7.11 or more in 90 days from now is roughly 2.87 (This Biostem Technologies probability density function shows the probability of Biostem OTC Stock to fall within a particular range of prices over 90 days) . Probability of Biostem Technologies price to stay between $ 7.11 and its current price of $14.44 at the end of the 90-day period is about 47.52 .
Given the investment horizon of 90 days Biostem Technologies has a beta of -0.65 suggesting as returns on the benchmark increase, returns on holding Biostem Technologies are expected to decrease at a much lower rate. During a bear market, however, Biostem Technologies is likely to outperform the market. Additionally Biostem Technologies has an alpha of 0.8259, implying that it can generate a 0.83 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta). Biostem Technologies Price Density |
| Price |
Predictive Modules for Biostem Technologies
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Biostem Technologies. Regardless of method or technology, however, to accurately forecast the otc stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the otc stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Biostem Technologies' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Biostem Technologies Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Biostem Technologies is not an exception. The market had few large corrections towards the Biostem Technologies' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Biostem Technologies, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Biostem Technologies within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | 0.83 | |
β | Beta against Dow Jones | -0.65 | |
σ | Overall volatility | 3.84 | |
Ir | Information ratio | 0.11 |
Biostem Technologies Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Biostem Technologies for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Biostem Technologies can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Biostem Technologies is way too risky over 90 days horizon | |
| Biostem Technologies appears to be risky and price may revert if volatility continues | |
| Biostem Technologies currently holds 1.32 M in liabilities. Biostem Technologies has a current ratio of 0.25, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist Biostem Technologies until it has trouble settling it off, either with new capital or with free cash flow. So, Biostem Technologies' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Biostem Technologies sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Biostem to invest in growth at high rates of return. When we think about Biostem Technologies' use of debt, we should always consider it together with cash and equity. | |
| The entity reported the previous year's revenue of 2.52 M. Net Loss for the year was (2.39 M) with profit before overhead, payroll, taxes, and interest of 163.78 K. | |
| Biostem Technologies currently holds about 1.37 M in cash with (581.57 K) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.12. | |
| Latest headline from MacroaxisInsider: Acquisition by Seidel-dugan Cynthia of 79516 shares of Werewolf Therapeutics at 11.55 subject to Rule 16b-3 |
Biostem Technologies Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Biostem OTC Stock often depends not only on the future outlook of the current and potential Biostem Technologies' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Biostem Technologies' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 9.2 M | |
| Short Long Term Debt | 4 M |
Biostem Technologies Technical Analysis
Biostem Technologies' future price can be derived by breaking down and analyzing its technical indicators over time. Biostem OTC Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Biostem Technologies. In general, you should focus on analyzing Biostem OTC Stock price patterns and their correlations with different microeconomic environments and drivers.
Biostem Technologies Predictive Forecast Models
Biostem Technologies' time-series forecasting models is one of many Biostem Technologies' otc stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Biostem Technologies' historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the otc stock market movement and maximize returns from investment trading.
Things to note about Biostem Technologies
Checking the ongoing alerts about Biostem Technologies for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Biostem Technologies help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Biostem Technologies is way too risky over 90 days horizon | |
| Biostem Technologies appears to be risky and price may revert if volatility continues | |
| Biostem Technologies currently holds 1.32 M in liabilities. Biostem Technologies has a current ratio of 0.25, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist Biostem Technologies until it has trouble settling it off, either with new capital or with free cash flow. So, Biostem Technologies' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Biostem Technologies sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Biostem to invest in growth at high rates of return. When we think about Biostem Technologies' use of debt, we should always consider it together with cash and equity. | |
| The entity reported the previous year's revenue of 2.52 M. Net Loss for the year was (2.39 M) with profit before overhead, payroll, taxes, and interest of 163.78 K. | |
| Biostem Technologies currently holds about 1.37 M in cash with (581.57 K) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.12. | |
| Latest headline from MacroaxisInsider: Acquisition by Seidel-dugan Cynthia of 79516 shares of Werewolf Therapeutics at 11.55 subject to Rule 16b-3 |
Other Information on Investing in Biostem OTC Stock
Biostem Technologies financial ratios help investors to determine whether Biostem OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Biostem with respect to the benefits of owning Biostem Technologies security.